The Worst Stock to Buy This January

AbbVie is one of the worst-performing stocks in January, historically

Managing Editor
Jan 7, 2022 at 10:23 AM
facebook X logo linkedin

As we say welcome in the New Year with cautious optimism, it’s important to note not just the best stock picks to bet on, but also the ones to avoid. Historically, there are a notable amount of names that tend to underperform the broader market in the month of January, and Schaeffer’s Senior Quantitative Analyst Rocky White has pulled the 25 worst to give a head start on how to keep your trading portfolio clean of any misses to start the year.

Taking the trophy for the worst stock on the S&P 500 Index (SPX) to own in January, historically, is pharmaceutical concern AbbVie Inc (NASDAQ:ABBV). Per White, over the last 10 years, ABBV stock carries the worst average return, negative 6.78%. Just two out of 10 returns have moved positive, and a move of similar magnitude from Thursday’s close of $135.93, would put AbbVie stock just below $127.


On the charts, ABBV has been running within record-high territory over the past few months but is now stalling out near $135, which could mean the equity has hit a top. In fact, the drug therapy name is sitting flat on the week despite Thursday hitting a record high of $136.83, further underscoring possible technical weakness.


Also supporting White’s data -- and Schaeffer’s signature contrarian angle -- is the analyst sentiment. Heading into Friday’s trading, 10 of the 13 brokerage firms in coverage boast a "buy" or "strong buy" recommendation. Should this optimism begin to unwind, it could put added pressure on ABBV shares.

Optimism is surging in the options pits as well. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), AbbVie stock sports a 50-day call/put volume ratio of 3.83, which stands higher than all other readings of the past 12 months. In other words, long calls are more popular than usual, leaving ample room for put traders to enter the ring.

Now might be a good opportunity for put traders to speculate on ABBV with options. The security sports a Schaeffer's Volatility Index (SVI) of 21% which sits in the relatively low volatility 23rd percentile of its annual range. In other words, options traders' volatility expectations aren't that high at the moment.

Subscribers to Chart of the Week received this commentary on Sunday, January 2.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI